MbrlCatalogueTitleDetail

Do you wish to reserve the book?
The Use of Stereotactic Excisional Biopsy in the Management of Invasive Breast Cancer
The Use of Stereotactic Excisional Biopsy in the Management of Invasive Breast Cancer
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
The Use of Stereotactic Excisional Biopsy in the Management of Invasive Breast Cancer
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
The Use of Stereotactic Excisional Biopsy in the Management of Invasive Breast Cancer
The Use of Stereotactic Excisional Biopsy in the Management of Invasive Breast Cancer

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
The Use of Stereotactic Excisional Biopsy in the Management of Invasive Breast Cancer
The Use of Stereotactic Excisional Biopsy in the Management of Invasive Breast Cancer
Journal Article

The Use of Stereotactic Excisional Biopsy in the Management of Invasive Breast Cancer

2005
Request Book From Autostore and Choose the Collection Method
Overview
Stereotactic breast biopsy techniques minimize the surgical trauma associated with conventional wire‐guided open breast biopsy for non‐palpable breast lesions (NPBLs). Advanced breast biopsy instrumentation (ABBI) allows for a 2‐cm core of breast tissue to be excised under stereotactic guidance in an outpatient setting. We report our initial experience with ABBI. Hospital charts from 89 ABBI procedures between 10/1996 and 07/2002 were retrospectively reviewed for patient characteristics, ABBI parameters, radiographic appearance, pathology, complications, and clinical follow‐up. Data are presented as percentage/median (range). Median age was 59 years (range: 39–80 years), mammographic lesions were classified as calcifications 49% (44/89), soft tissue 39% (35/89), or mixed 11% (10/89). Median radiographic size was 7 mm (1–60 mm). Final pathology revealed ductal carcinoma in situ (DCIS) in 7% (6/89) and invasive cancer in 22% (20/89). Microscopically clear margins were obtained in 55% (11/20) of patients with invasive cancer. Of these, 82% (9/11) chose not to undergo further local surgical therapy. Eight patients remain disease free at 56 months (range: 41–95 months) follow‐up. The ninth patient was deceased at 6 months from an unrelated cause. The overall complication rate was 3% (3/89). A definitive diagnosis was obtained in 100% of malignant and 87% of benign cases. Median waiting time was 19 days (range: 0–90 days). Our experience demonstrates that ABBI is an effective diagnostic tool for NPBLs. It is associated with minimal complications, and provides negative margins in over half of malignant cases. In selected patients with invasive cancer and negative margins, ABBI may obviate the need for further local surgical treatment. ABBI merits additional investigation as a therapeutic modality for early breast cancer.